GRI Disclosure Number |
GRI Standard Title |
Disclosure Title |
Reference 2021 |
102 - GENERAL DISCLOSURES |
|
|
|
GRI 102-1 |
General Disclosures |
Name of the organization |
About Roche |
GRI 102-10 |
General Disclosures |
Significant changes to the organization and its supply chain |
Annual Report 2021, p.14 |
GRI 102-11 |
|
Precautionary Principle or approach |
Our Approach to Non-Financial Reporting |
GRI 102-12 |
General Disclosures |
External initiatives |
Memberships
and International CR Recommendations |
|
|
|
Stakeholder engagement (view section "government authorities, industry bodies and other associations") |
GRI 102-13 |
General Disclosures |
Membership of associations |
Non-Financial Reporting |
|
|
|
Stakeholder Engagement |
|
|
|
Public Policy |
|
|
|
Working
with Patient Organisations |
GRI 102-14 |
General Disclosures |
Statement from the most senior decision-maker |
Annual Report 2021, pp. 13-18 |
GRI 102-16 |
General Disclosures |
Values, principles, standards and norms of behavior |
The Roche Group Code
of Conduct |
|
|
|
Meeting High Standards of Business Ethics |
|
|
|
Our values
|
GRI 102-17 |
General Disclosures |
Mechanisms for advice and concerns about ethics |
Ethical Standards |
|
|
|
Non-Financial Reporting (view KPis "Roche Group SpeakUp Line cases" & "Alleged Business Ethics Incidents") |
|
|
|
Code of Conduct |
GRI 102-18 |
General Disclosures |
Governance structure |
Chief
Compliance Officer |
|
|
|
Governance |
|
|
|
Our approach to
sustainability |
GRI 102-2 |
General Disclosures |
Activities, brands, products, and services |
Products
|
|
|
|
Pipeline |
|
|
|
Our
Business |
GRI 102-3 |
General Disclosures |
Location of headquarters |
Location of Headquarters |
GRI 102-4 |
General Disclosures |
Location of operations |
Roche affiliates worldwide |
GRI 102-40 |
General Disclosures |
List of stakeholder groups |
Stakeholder Engagement |
GRI 102-41 |
General Disclosures |
Collective bargaining agreements |
Non-Financial Reporting |
|
|
|
Employment Policy |
GRI 102-42 |
General Disclosures |
Identifying and selecting stakeholders |
Stakeholder
engagement |
GRI 102-44 |
General Disclosures |
Key topics and concerns raised |
Materiality |
GRI 102-45 |
General Disclosures |
Entities included in the consolidated financial statements |
Finance Report 2021, p. 138 |
GRI 102-46 |
General Disclosures |
Defining report content and topic Boundaries |
Annual Report 2021, p. 22 |
|
|
|
Reporting (view section "Reporting Scope") |
GRI 102-47 |
General Disclosures |
List of material topics |
Materiality |
GRI 102-48 |
General Disclosures |
Restatements of information |
Non-Financial Reporting |
|
|
|
Finance Report, p.61 |
GRI 102-49 |
General Disclosures |
Changes in reporting |
Annual Report, p.22 |
GRI 102-5 |
General Disclosures |
Ownership and legal form |
Articles of Incorporation Roche Holding Ltd
|
|
|
|
Governance |
GRI 102-50 |
General Disclosures |
Reporting period |
Reporting (view section reporting scope) |
GRI 102-51 |
General Disclosures |
Date of most recent report |
Annual Report 2021 (2021) |
GRI 102-52 |
|
Reporting cycle |
Annual Report 2021 (Yearly) |
GRI 102-54 |
General Disclosures |
Claims of reporting in accordance with the GRI Standards |
Roche GRI Index |
GRI 102-56 |
General Disclosures |
External assurance |
Annual Report, pp. 190-193 |
|
|
|
Independent Reasonable and Limited Assurance Report on 2021 non-financial reporting |
GRI 102-6 |
General Disclosures |
Markets and sectors served |
Roche Markets |
|
|
|
Focus Areas |
GRI 102-7 |
General Disclosures |
Scale of the organization |
Non-Financial Reporting (view KPIs number of employees ) |
|
|
|
Our Business |
|
|
|
Roche
worldwide |
GRI 102-8 |
General Disclosures |
Information on employees and other workers |
Our People and Culture |
|
|
|
Non-Financial Reporting (view all employee-related KPIs) |
GRI 102-9 |
General Disclosures |
Supply chain |
Working with Suppliers |
103 - MANAGEMENT APPROACH |
|
|
|
GRI 103-1 |
Management Approach |
Explanation of the material topic and its Boundary |
Materiality |
GRI 103-2 |
Management approach |
Management approach and its components |
Materiality (view sections "What are we doing about it?") |
200 -ECONOMIC |
|
|
|
GRI 201-1 |
Economic Performance |
Direct economic value generated and distributed |
Non-Financial Reporting (view section "Our economic impact") |
GRI 202-1 |
Market Presence |
Ratios of standard entry level wage by gender compared to local minimum
wage |
Non-Financial Reporting (view section "Our economic impact") |
GRI 203-2 |
Indirect Economic Impacts |
Significant indirect economic impacts |
Materiality
|
|
|
|
Suppliers and service
providers |
GRI 204-1 |
Procurement Practices |
Proportion of spending on local suppliers |
Suppliers
Goals and Performance |
GRI 205-1 |
Anti-Corruption |
Operations asessed for risks related to corruption |
Procurement Risk Management |
|
|
|
Risk Management |
GRI 206-1 |
Anti-Competitive Behaviour |
Legal actions for anti-competitive behavior, anti-trust, and monopoly
practices |
Roche Directive on Competition Law |
300 -ENVIRONMENT |
|
|
|
GRI 301-1 |
Materials |
Materials used by weight or volume |
Resources
and Raw Materials |
|
|
|
Environment |
GRI 302-3 |
Energy |
Energy intensity |
Resources
and Raw Materials |
|
|
|
Non-Financial Reporting (view "Our environmental impact" section) |
|
|
|
Environment |
GRI 303-1 |
Water |
Water withdrawal by source |
Resources
and Raw Materials |
|
|
|
Non-Financial Reporting (view "Our environmental impact" section) |
|
|
|
Environment |
GRI 304-3 |
Biodiversity |
Habitats protected or restored |
Kesslergrube remediation site |
|
|
|
Recycling
and Waste Management |
GRI 305-4 |
Emissions |
Greenhouse gas (GHG) emissions intensity |
Minimising our Environmental Footprint |
|
|
|
Our Non-Financial Reporting (view "our environmental impact" section) |
GRI 306-1 |
Effluents and Waste |
Waste generation and significant waste-related impacts |
Recycling & Waste Management |
|
|
|
Non-Financial Reporting (view "Our environmental impact" section) |
GRI 307-1 |
Environmental Compliance |
Non-compliance with environmental laws and regulations |
Our SHE Goals & Performance (view section "Conducting SHE audits") |
GRI 308-2 |
Supplier Environmental Assessment |
Negative environmental impacts in the supply chain and actions taken |
Procurement Goals & Performance |
|
|
|
Working with our Suppliers |
400 -SOCIAL |
|
|
|
GRI 401-1 |
Employment |
New employee hires and employee turnover |
Code of Conduct p. 18 |
|
|
|
Our Non-Financial Reporting (view "Total number of new employee hires" and "Employee total turnover rate" KPIs) |
GRI 402-1 |
Labor/Management Relations |
Minimum notice periods regarding operational changes |
Roche Group Employment Policy |
GRI 403-1 |
Occupational Health and Safety |
Workers representation in formal joint management-worker health and safety
committees |
Safety, Security, Health and Environmental Protection in the Roche Group |
GRI 404-2 |
Training and Education |
Programs for upgrading employee skills and transition assistance programs
|
Roche Careers |
|
|
|
Our People and Culture |
GRI 405-1 |
Diversity and Equal Opportunity |
Diversity of government bodies and employees |
Non-Financial Reporting (view KPIs on employees) |
GRI 405-2 |
Diversity and Equal Opportunity |
Ratio of basic salary and remuneration of women to men |
Roche Group Employment Policy |
GRI 406-1 |
Non-discrimination |
Incidents of discrimination and corrective actions taken |
Roche Code of Conduct Discrimination and Harassments |
GRI 407-1 |
Freedom of Association and Collective Bargaining |
Operations and suppliers in which the right to freedom of assocation and collective
bargaining may be at risk |
Roche Group Employment Policy |
GRI 408-1 |
Child Labor |
Operations and suppliers at significant risk for incidents of child labor
|
Supplier Sustainability Principles |
GRI 409-1 |
Forced or Compulsory Labor |
Operatinos and suppliers at significant risk for incidents of forced or compulsory
labor |
Human Rights (view section "working conditions") |
GRI 410-1 |
Security Practices |
Security personnel trained in human rights policies or procedures |
Supplier Sustainability Principles |
GRI 411-1 |
Rights of Indigenous Peoples |
Incidents of violations involving rights of indigenous people |
|
GRI 412-1 |
Human Rights Assessment |
Operations that have been subject to human rights reviews or impact
assessments |
Human Rights in the Supply Chain |
GRI 412-3 |
Human Rights Assessment |
Significant investment agreements and contracts that include human rights clauses or
that underwent human rights screening |
Human Rights in the Supply Chain |
GRI 413-1 |
Local Communities |
Operations with local community engagement, impact assessments, and development
programs |
Strengthening Communities |
|
|
|
Rebuilding Communities |
GRI 414-1 |
Supplier Social Assessment |
New suppliers that were screened using social criteria |
Working with Suppliers |
|
|
|
Supplier Code of Conduct |
GRI 414-2 |
Supplier Social Assessment |
Negative social impacts in the supply chain and actions taken |
Supplier
Code of Conduct |
|
|
|
Human Rights in the Supply Chain
|
GRI 415-1 |
Public Policy |
Political contributions |
Our Approach to Public Policy |
GRI 416-1 |
Customer Health and Safety |
Assessment of the health and safety impacts of product and service
categories |
Medical information
|
GRI 417-1 |
Marketing and Labeling |
Requirements for product and service information and labeling |
Anti-Counterfeiting
|
GRI 418-1 |
Customer Privacy |
Substantiated complaints concerning breaches of customer privacy and losses of
customer data |
Our Commitment to Data Sharing |
|
|
|
Roche Global Policy on Sharing of Clinical Study Information |
GRI 419-1 |
Socioeconomic Compliance |
Non-compliance with laws and regulations in the social and economic area
|
Finance Report 2021, pp. 88-90 |